PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30879681-0	2019	Inhibition of tumor growth by beta-glucans through promoting CD4+ T cell immunomodulation and neutrophil-killing in mice.	beta-Glucans	30-42	CD4 antigen	Mus musculus	61-64	
30879681-4	2019	It was found that beta-glucans up-regulated CD4+ T cell level in lymphoid organs decreased by tumor-burden, indicating promotion of immunomodulation.	beta-Glucans	18-30	CD4 antigen	Mus musculus	44-47	
30879681-6	2019	Furthermore, beta-glucans not only targeted to lymphoid organs and increased CD4+ T cells number, but also enhanced CD4+ T cells and neutrophils populations in tumors.	beta-Glucans	13-25	CD4 antigen	Mus musculus	77-80	
30879681-6	2019	Furthermore, beta-glucans not only targeted to lymphoid organs and increased CD4+ T cells number, but also enhanced CD4+ T cells and neutrophils populations in tumors.	beta-Glucans	13-25	CD4 antigen	Mus musculus	116-119	
30879681-7	2019	It was proposed that beta-glucans promoted CD4+ T cell immunomodulation and neutrophils infiltration into tumors, leading to tumor growth inhibition.	beta-Glucans	21-33	CD4 antigen	Mus musculus	43-46	
21636079-0	2011	Increased expression of mGITRL on D2SC/1 cells by particulate beta-glucan impairs the suppressive effect of CD4+CD25+ regulatory T cells and enhances the effector T cell proliferation.	beta-Glucans	62-73	CD4 antigen	Mus musculus	108-111